GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4R(1)(a) and (c) I give details of changes in the interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR') who acquired Ordinary Shares ('Shares') in GlaxoSmithKline plc ('GSK') at a price of 1367.57 pence per Share, following the re-investment of the dividend paid to shareholders on 14 January 2016.
|
Director/PDMR
|
Shares |
|
Sir Andrew Witty
|
28.610 |
|
Mr S Dingemans |
937.309 |
|
Mr S A Hussain |
30.863 |
|
Mr D S Redfern |
813.543 |
|
Dr M M Slaoui |
164.460 |
|
Ms C Thomas |
998.661 |
|
Mr P C Thomson |
341.837 |
|
Dr P J T Vallance
|
1,210.723 |
|
Ms E Walmsley
|
939.015 |
|
Connected Person |
Shares |
|
Mrs K Thomson (Connected Person to Mr P C Thomson)
|
110.075 |
GSK was informed of these allocations on 28 January 2016.
V A Whyte
Company Secretary
1 February 2016